Swift's 'Patient Zero' Tops Global Charts, Ending Langley's 24-Week Reign

Taylor Swift's new single 'Patient Zero' debuted at No. 1 on both the Billboard Global 200 and Global Excl. U.S. charts, marking her eighth and fifth respective No. 1s on those tallies. The track, from the deluxe reissue 'The Life of a Showgirl: The Encore,' also claimed the top spot on the U.S. Hot 100, ending Ella Langley's record-breaking 24-week run with 'Choosin' Texas.' All four new tracks from the reissue entered the top 10 of global rankings, with the album itself returning to No. 1 on the Billboard 200 for a 13th cumulative week.
Key points
- 'Patient Zero' launched at No. 1 on the Billboard Global 200 and Global Excl. U.S. charts, with 70.7 million streams and 80,000 sales globally in its first week.
- The single became Swift's 16th No. 1 on the U.S. Hot 100, tying Drake for the most No. 1 debuts in the chart's history.
- Ella Langley's 'Choosin' Texas' dropped to No. 2 on the Hot 100 after holding the top spot for 24 weeks.
- The other three new tracks from the 'Encore' reissue, 'Cleveland!,' 'Babylon,' and 'Pink Clouding,' all entered the top 10 of global charts.
- The 'Encore' reissue helped 'The Life of a Showgirl' return to No. 1 on the U.S. Billboard 200 for a 13th cumulative week.
Background
The 'Encore' deluxe edition was released on September 25, 2026, adding four new tracks to Swift's 2025 album 'The Life of a Showgirl.' The release was described as a thank-you to fans for the original album's record-breaking sales. The 'Patient Zero' music video, directed by Swift and starring Dakota Johnson and Colin Farrell, premiered at the 2026 MTV VMAs on September 27. The album had previously spent nine months off the top of the U.S. Billboard 200 before this resurgence.
How outlets are covering it
Billboard emphasizes the global dominance of 'Patient Zero,' highlighting its No. 1 debut on both global charts and Swift's record-tying achievements. Variety focuses on the U.S. Hot 100, noting how Swift's four new tracks occupied the top five slots and displaced Ella Langley's long-running No. 1. Rolling Stone highlights Swift's 16th career No. 1 and her status as one of only two female solo artists to achieve four No. 1 hits in a single year. All outlets agree on the commercial success of the 'Encore' reissue but differ in their emphasis on global versus U.S. chart performance.
Why it matters
The success of 'Patient Zero' and the 'Encore' reissue demonstrates Swift's continued ability to dominate multiple chart formats simultaneously, reinforcing her status as a leading commercial force in the music industry. The displacement of Ella Langley's record-breaking run also highlights the competitive nature of the current chart landscape.
What to watch
Swift is expected to hold the No. 1 spot on the Hot 100 for a second week, bolstered by the release of physical copies of 'Patient Zero.' The coming weeks will determine whether Ella Langley can reclaim the No. 1 spot before Mariah Carey's 'All I Want for Christmas Is You' typically re-enters the chart in December.
- Taylor Swift’s ‘Patient Zero’ Debuts at No. 1 on Global Charts Billboard
- Taylor Swift’s ‘Patient Zero’ Debuts at No. 1 on Billboard Hot 100 Billboard
- Taylor Swift's 'Patient Zero' Bumps 'Choosin' Texas' Out of No. 1 Variety
- Taylor Swift Nabs Yet Another Number One Song With ‘Patient Zero’ Rolling Stone
- Video Taylor Swift's 'Patient Zero' debuts at No. 1 ABC News - Breaking News, Latest News and Videos
Want the full story? Read the original reporting
Read on Billboard